| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.0M | +142.6% |
| R&D Expense | $39.6M | -20.5% |
| SG&A Expense | $32.0M | -8.9% |
| Operating Income | -$65.5M | +22.8% |
| Pre-tax Income | -$63.1M | +22.5% |
| Income Tax | $0 | — |
| Net Income | -$63.1M | +22.5% |
| EPS (Basic) | -$0.26 | +31.6% |
| EPS (Diluted) | -$0.26 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.5M | -49.1% |
| Current Assets | $43.0M | -56.4% |
| Total Assets | $64.5M | -40.6% |
| Current Liabilities | $17.1M | -7.4% |
| Long-term Debt | $2.8M | +22.3% |
| Total Liabilities | $24.0M | -2.4% |
| Stockholders' Equity | $40.6M | -51.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.1M | -3.3% |
| Capital Expenditures | $10.5M | +135.0% |
| Investing Cash Flow | $3.1M | +118.1% |
| Financing Cash Flow | $20.9M | -64.9% |
| Free Cash Flow | -$72.5M | -12.4% |
| +31.6% |